|
WO2014135984A2
|
|
Glycosylated mucin-immunoglobulin fusion protein coated device
|
|
AU2013204832A1
|
|
Compositions and methods for inhibiting viral adhesion
|
|
EP2654771A1
|
|
Tear substitutes
|
|
AU2009245358A1
|
|
Compositions and methods for inhibiting shiga toxin and shiga-like toxin
|
|
US2009280134A1
|
|
Compositions and methods for inhibiting toxin a from clostridium difficile
|
|
CA2635011A1
|
|
Use of sialylated fusion polypeptides for inhibition of oculotropic viruses
|
|
CA2637947A1
|
|
Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof
|
|
EP1984504A2
|
|
Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof
|
|
EP1799714A1
|
|
Composition and methods for inhibiting h. pylori adhesion and infection
|
|
US2006177463A1
|
|
Compositions and methods for inhibiting H. pylori adhesion and infection
|
|
AU2003263411A1
|
|
Mucin-Immunoglobulin fusion proteins
|
|
AU2003233008A1
|
|
Fusion polypeptides and methods for inhibiting microbial adhesion
|
